FGF2 and endometrium neoplasm: However, medroxyprogesterone acetate (MPA), a synthetic progestin, suppresses bFGF expression and secretion in well-differentiated uterine endometrial tumor cells, while it has no effect on poorly differentiated uterine endometrial tumor cells [67].